NEVVI Medicare utilization intelligence

← back

SHEELA, SHEENUMD NPI 1164685202 Clinician

Hematology-Oncology · BLACKSBURG, VA

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location BLACKSBURG, VA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 70 codes billed · 115,423 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20212026
ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA INC
2022–2026
THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY
2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1437 Injection, ferric derisomaltose, 10 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
J2469 Injection, palonosetron hcl, 25 mcg
J9395 Injection, fulvestrant, 25 mg
36415 Insertion of needle into vein for collection of blood sample
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3489 Injection, zoledronic acid, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J3475 Injection, magnesium sulfate, per 500 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J9045 Injection, carboplatin, 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82784 Gammaglobulin (immune system protein) measurement
82728 Ferritin (blood protein) level
83550 Iron binding capacity
83540 Iron level
84443 Blood test, thyroid stimulating hormone (tsh)
96372 Injection of drug or substance under skin or into muscle
83521 Measurement of immunoglobulin light chains
J3480 Injection, potassium chloride, per 2 meq
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83615 Lactate dehydrogenase (enzyme) level
84439 Thyroxine (thyroid chemical), free
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3490 Unclassified drugs
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
84153 Psa (prostate specific antigen) measurement, total
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
84481 Thyroid hormone, t3 measurement, free
82232 Beta-2 microglobulin (protein) level
82607 Cyanocobalamin (vitamin b-12) level
96361 Infusion into a vein for hydration, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J1885 Injection, ketorolac tromethamine, per 15 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99441 Telephone medical discussion with physician, 5-10 minutes
82378 Carcinoembryonic antigen (cea) protein level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99195 Drawing of blood for a medical problem
96360 Infusion into a vein for hydration, 31-60 minutes
96374 Injection of drug or substance into vein
96523 Irrigation of implanted venous access drug delivery device
81002 Urinalysis, manual test
83735 Magnesium level
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
84480 Thyroid hormone, t3 measurement, total
99442 Telephone medical discussion with physician, 11-20 minutes
84550 Uric acid level, blood
84436 Thyroxine (thyroid chemical), total
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.